sGjROPEAN PHARMACOPOEIA 10.0
(01/2008:30200
corrected 10.0
I container or pharmaceutea! use san atl th@ contain
sin i Perot und ice maybe re
ere eteare be yu hc
re are ener Nt econ dened
Peer
ee eon, panda ng
ree of protection depending on the néture of the product
«ee hazards of the environment, 34 annimises the loss
Hee ee eect ee inet peal o
Fe ac Fag ooliy
See a ee aa puta sua
“pean mene gee contol
Fe art an lata ruler peel
Bete rales en
nun Sane
of the preparation suits for 2 OyaRore doses.
‘Wellclosed container. Yowell-closbd Cdntainer protects the
_{ontents from contarpination with extraneous solids and
Jiquids and from losé of contents under ordinary conditions of
Suancling storage ghd transport
‘Airtight containeh An aictight container is impermesble
th solids, iquigé and goses under ordinary conditions of
“Thndling stopfge and transport. If the container is intended
fobe openedon more than 1 occasion it must be so designed
airtight after e-losire
| Tamperfevident container. A tamper-evident container isa
‘ontainer fitted with a device that reveals ireversibly
fer the container has been opened.
f-proof container. A container that is fitted with a closure
{prevents opening by children.
(01/2019:30201
3.2.1, GLASS CONTAINERS FOR
_ PHARMACEUTICAL USE
Glass containers for pharmaceatical use are glass articles
intended to come into direct contact with pharmaceutical
reparations.
_Colourless glass is highly transparent inthe visible spectrum,
Coloured glass is obtained by the addition of small amounts
of metal oxides, chosen according to the desired spectral
Absorbance
Neutral glass is a borosilicate glass containing significant
“amounts of bori oxide, aluminium oxide, alkali metal oxides
| andlor alkaline earth oxides in the glass network. Du to its
|